Pharmacology Exam Questions
1. In which patient population is Metformin contraindicated in?
A. Diabetics with HA1c < 7.0%
B. Patients older than 50
C. Alcoholics
D. Women suffering from infertility
C. Alcoholics
2. What lab value suggests metformin might be contraindicated?
A. eGFR <30
B. Crea 0.8
C. WBC 7.8
D. Bun 17
A. eGFR <30
3. What medication is contraindicated to treat diabetes if a patient
already has a cardiac ejection fraction rate of 40%?
A. Second Generation sulfonyureas
B. Thiazolidinediones
C. Dopamine Agonist
D. Glucosidase Inhibitor
B. Thiazolidinediones
4. Sabrina is a 35-year-old female who presents with complaints of
fatigue, anxiety, and palpitations. She has a long history of obesity
and reports that she is happy that she has lost 23 pounds in the last 2
months. She also reports that she has trouble sleeping and her
husband complains that she is keeping the house too cold. Physical
exam reveals slight tachycardia at 104 bpm and a slightly enlarged
thyroid. Thyroid testing reveals hyperthyroidism or Grave's disease.
Which of the following agents is the first-line treatment for
hyperthyroidism or Grave's disease?
A. Methimazole
B. Metoprolol
C. Allopurinol
D. Levothyroxine
, A. Methimazole
5. Which of the following medications would be considered the first line
of treatment for a newly diagnosed Diabetic patient with adequate
renal and hepatic function?
A: NovoLog Sliding Scale Insulin
B: Liraglutide (Victoza)
C: Oral Metformin
D: Glipizide
C: Oral Metformin
6. Of the following medications, which is most likely to cause
hypoglycemia?
A. Metformin
B. Insulin
C. Incretin mimetics
D. Thiazolidinediones
B. Insulin
7. Which symptoms are most expected of a patient diagnosed with
hypothyroidism?
A. shortness of breath, wheezing, fatigue
B. tachycardia, insomnia, weight loss, goiter
C. irritability, anxiety, dizziness, increased sweating
D. dry pale skin, brittle hair, fatigue, myxedema
D. dry skin, brittle hair, fatigue, myxedema
8. Patients with an increased risk for UTIs and genital infections or an
active diagnosis, should avoid what drug class/es for treatment of
Type II Diabetes?
A. Thiazolidinediones (Glitazones)
B. Biguanide.
C. Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
D. All of the above.
C. Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
, 9. A 45-year-old patient with a history of type 2 diabetes presents to the
clinic for a follow-up appointment. The healthcare provider has
prescribed metformin as part of the treatment plan. Which of the
following statements regarding metformin is correct?
A. Metformin primarily stimulates insulin production from the
pancreas.
B. Metformin reduces glucose levels primarily by decreasing insulin
resistance.
C. Metformin is associated with a risk of hypoglycemia.
D. Metformin improves insulin sensitivity and reduces hepatic
glucose production.
D. Metformin improves insulin sensitivity and reduces hepatic
glucose production.
10. In what part of the body are SGLT-2 (sodium-glucose cotransporter 2)
inhibitors active?
A. Small intestine
B. Pancreas
C. Renal tubules
D. Stomach
C. Renal tubules
11. Which of the following statements is not true regarding
sulfonylureas?
A. Sulonlyreas are safe to prescribe to pregnant and/or breast-feeding
women.
B. Patients should be educated about signs and symptoms of
hypoglycemia.
C. Sulfonylureas cause a dose-dependent reduction in blood glucose.
D. Sulfonylureas are indicated for only patients diagnosed with type 2
diabetes.
A. Sulonlyreas are safe to prescribe to pregnant and/or breast-feeding
women.